| Flynn James E |
Non-Executive |
Bicara Therapeutics Inc. (BCAX)
|
2024-09-17 |
$18.00 |
0.0% |
70,000
|
$1,260,000 |
| Flynn James E |
Non-Executive Director |
Larimar Therapeutics, Inc. (LRMR)
|
2024-02-16 |
$8.74 |
1.8% |
4,290,617
|
$37,499,993 |
| Flynn James E |
Non-Executive Director |
Nuvalent, Inc. (NUVL)
|
2022-11-03 |
$33.50 |
153.6% |
650,000
|
$21,775,000 |
| Flynn James E |
Non-Executive Director |
Larimar Therapeutics, Inc. (LRMR)
|
2022-09-16 |
$3.15 |
182.5% |
11,111,108
|
$34,999,990 |
| Flynn James E |
Non-Executive |
PepGen Inc. (PEPG)
|
2022-05-10 |
$12.00 |
-26.2% |
416,666
|
$4,999,992 |
| Flynn James E |
Non-Executive |
Xilio Therapeutics, Inc. (XLO)
|
2021-10-26 |
$16.00 |
-95.2% |
775,000
|
$12,400,000 |
| Flynn James E |
Non-Executive Director |
Acutus Medical, Inc. (AFIB)
|
2021-07-19 |
$14.00 |
-99.8% |
1,071,428
|
$14,999,992 |
| Flynn James E |
Non-Executive Director |
Larimar Therapeutics, Inc. (LRMR)
|
2021-06-30 |
$8.75 |
1.7% |
685,710
|
$5,999,962 |
| Flynn James E |
Non-Executive |
Singular Genomics Systems, Inc. (OMIC)
|
2021-06-01 |
$660.00 |
-99.1% |
50,000
|
$33,000,000 |
| Flynn James E |
Non-Executive |
Werewolf Therapeutics, Inc. (HOWL)
|
2021-05-04 |
$16.00 |
-87.3% |
800,000
|
$12,800,000 |
| Flynn James E |
Non-Executive |
Edgewise Therapeutics, Inc. (EWTX)
|
2021-03-30 |
$16.00 |
9.2% |
625,000
|
$10,000,000 |
| Flynn James E |
Non-Executive Director |
Oncorus, Inc. (ONCR)
|
2021-02-17 |
$19.00 |
-99.3% |
300,000
|
$5,700,000 |
| Flynn James E |
Non-Executive |
Terns Pharmaceuticals, Inc. (TERN)
|
2021-02-09 |
$17.00 |
-56.1% |
665,000
|
$11,305,000 |
| Flynn James E |
Non-Executive Director |
Oncorus, Inc. (ONCR)
|
2020-10-06 |
$15.00 |
-99.2% |
1,000,000
|
$15,000,000 |
| Flynn James E |
Non-Executive |
GRAYBUG VISION, INC. (GRAY)
|
2020-09-29 |
$224.00 |
-97.6% |
111,607
|
$25,000,000 |
| Flynn James E |
Non-Executive Director |
Acutus Medical, Inc. (AFIB)
|
2020-08-10 |
$18.00 |
-99.8% |
1,500,000
|
$27,000,000 |
| Flynn James E |
Non-Executive |
Annexon, Inc. (ANNX)
|
2020-07-28 |
$17.00 |
-65.8% |
700,000
|
$11,900,000 |
| Flynn James E |
Non-Executive |
Nkarta, Inc. (NKTX)
|
2020-07-14 |
$18.00 |
-69.8% |
1,000,000
|
$18,000,000 |
| Flynn James E |
Non-Executive |
Generation Bio Co. (GBIO)
|
2020-06-16 |
$19.00 |
-87.8% |
225,000
|
$4,275,000 |
| Flynn James E |
Non-Executive |
Revolution Medicines, Inc. (RVMD)
|
2020-02-18 |
$17.00 |
154.4% |
600,000
|
$10,200,000 |
| Flynn James E |
Non-Executive |
Schrodinger, Inc. (SDGR)
|
2020-02-10 |
$17.00 |
20.7% |
250,000
|
$4,250,000 |
| Flynn James E |
Non-Executive |
Black Diamond Therapeutics, Inc. (BDTX)
|
2020-02-03 |
$19.00 |
-70.6% |
400,000
|
$7,600,000 |
|
|
|
|
|
Return |
Profit / (loss) |
Cost |
|
|
|
Total |
|
-19.4% |
$-63,993,810 |
$329,964,929 |